Key facts
- Abbelight’s last known valuation is $12.4M (Mar 2023).
- It has raised $5.9M; the latest was Later Stage VC in Jan 2026.
- Notable investors include European Innovation Council, Agoranov, General Inception, Odyssee Venture, Avant Bio — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Abbelight
- ·The full record, as it builds
Funding rounds
No funding rounds for Abbelight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Abbelight
Developer of a modular product technology designed to provide single-molecule localization microscopy to researchers. The company's technology offers single-molecule localization microscopy that is a combination of consumable, hardware, and software techniques to achieve reliable state-of-the-art science, enabling companies conducting research in the fields of biology, pharmacology, and environment to implement super-resolved fluorescence microscopy approaches to observe biological samples with improved resolution.
- Sector
- Information Technology
- HQ
- Cachan, France
- Founded
- 2016
- Employees
- 60
- Website
- abbelight.com/
- Ownership
- Privately Held (backing)
Abbelight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Abbelight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Abbelight in its N-PORT filings yet. We sweep new filings monthly.